J.A.J.A.SquellaJ.A.J.A. i inni, Electrochemical generation and interaction study of the nitro radical anion from nimesulide, „Pharmaceutical Research”, 16 (1), 1999, s. 161–164, DOI: 10.1023/A:1011950218824, PMID: 9950296.
MayM.HamzaMayM., Raymond A.R.A.DionneRaymond A.R.A., Mechanisms of Non-Opioid Analgesics Beyond Cyclooxygenase Enzyme Inhibition, „Current Molecular Pharmacology”, 2 (1), Bentham Science, 2009, s. 1–14, DOI: 10.2174/1874467210902010001, PMID: 19779578, PMCID: PMC2749259.
K.D.K.D.RainsfordK.D.K.D., Anti-Inflammatory Drugs of the 21st Century, [w:] Inflammation in the Pathogenesis of Chronic Diseases, R.E.R.E.Harris (red.), Springer, 2007 (Subcellular Biochemistry, t. 42), s. 3–27, DOI: 10.1007/1-4020-5688-5_1, ISBN 978-1-4020-5688-8.
MatteoM.LazzeroniMatteoM. i inni, Breast ductal lavage for biomarker assessment in high risk women: rationale, design and methodology of a randomized phase II clinical trial with nimesulide, simvastatin and placebo, „BMC Cancer”, 12, 2012, s. 578, DOI: 10.1186/1471-2407-12-575, PMID: 23216985, PMCID: PMC3522001.
R.R.VillaR.R. i inni, Oral and intravenous administration of nimesulide in the horse: rational dosage regimen from pharmacokinetic and pharmacodynamic data, „Equine Veterinary Journal”, 39, 2007, s. 136–142, DOI: 10.2746/042516407X159123, PMID: 17378442.
P.L.P.L.ToutainP.L.P.L. i inni, A pharmacokinetic/pharmacodynamic approach vs. a dose titration for the determination of a dosage regimen: the case of nimesulide, a COX-2 selective nonsteroidal anti-inflammatory drug in the dog, „Journal of Veterinary Pharmacology and Therapeutics”, 24 (1), 2001, s. 43–55, DOI: 10.1046/j.1365-2885.2001.00304.x, PMID: 11348486.
AlbertoA.BernareggiAlbertoA., Clinical pharmacokinetics and metabolism of nimesulide, „InflammoPharmacology”, 9 (1–2), 2001, s. 81–99, DOI: 10.1163/156856001300248353, PMID: 9812177.
C.Mattia i inni, Nimesulid – 25 lat później, „Minerva Medica”, 101, 2010, s. 4, PMID: 21030939.
U.A.U.A.BoelsterliU.A.U.A., Nimesulide and hepatic adverse effects: roles of reactive metabolites and host factors, „International Journal of Clinical Practice”, 128, 5th Congress of the European Association for Clinical Pharmacology and Therapeutics, 2002, s. 30–36, PMID: 12166617.
J.A.J.A.SquellaJ.A.J.A. i inni, Electrochemical generation and interaction study of the nitro radical anion from nimesulide, „Pharmaceutical Research”, 16 (1), 1999, s. 161–164, DOI: 10.1023/A:1011950218824, PMID: 9950296.
MayM.HamzaMayM., Raymond A.R.A.DionneRaymond A.R.A., Mechanisms of Non-Opioid Analgesics Beyond Cyclooxygenase Enzyme Inhibition, „Current Molecular Pharmacology”, 2 (1), Bentham Science, 2009, s. 1–14, DOI: 10.2174/1874467210902010001, PMID: 19779578, PMCID: PMC2749259.
MatteoM.LazzeroniMatteoM. i inni, Breast ductal lavage for biomarker assessment in high risk women: rationale, design and methodology of a randomized phase II clinical trial with nimesulide, simvastatin and placebo, „BMC Cancer”, 12, 2012, s. 578, DOI: 10.1186/1471-2407-12-575, PMID: 23216985, PMCID: PMC3522001.
R.R.VillaR.R. i inni, Oral and intravenous administration of nimesulide in the horse: rational dosage regimen from pharmacokinetic and pharmacodynamic data, „Equine Veterinary Journal”, 39, 2007, s. 136–142, DOI: 10.2746/042516407X159123, PMID: 17378442.
P.L.P.L.ToutainP.L.P.L. i inni, A pharmacokinetic/pharmacodynamic approach vs. a dose titration for the determination of a dosage regimen: the case of nimesulide, a COX-2 selective nonsteroidal anti-inflammatory drug in the dog, „Journal of Veterinary Pharmacology and Therapeutics”, 24 (1), 2001, s. 43–55, DOI: 10.1046/j.1365-2885.2001.00304.x, PMID: 11348486.
BłażejB.PóźniakBłażejB., MarcinM.ŚwitałaMarcinM., Salicylany w farmakoterapii weterynaryjnej. Część II. Wskazania do stosowania u ptaków oraz działania niepożądane i toksyczność, „Życie Weterynaryjne”, 87, 2012, s. 1038–1041, ISSN0026-4806.
